Skip to content
WeightLossDrugsGuide

Independent educational reference. Not a pharmacy, medical provider, or telehealth clinic — and not a substitute for medical advice.

Manufacturer Savings and Assistance Programs

Manufacturers of weight-management medications operate savings cards, direct self-pay pharmacy channels, and patient assistance programs. Eligibility rules almost always exclude people with government insurance such as Medicare or Medicaid, and both eligibility and dollar amounts change frequently. Because these terms are volatile, this page explains how the programs work and links to the official pages rather than quoting figures.

Key facts

  • Savings cards are typically limited to patients with commercial (non-government) insurance.
  • Self-pay channels sell directly to patients who are paying cash, at prices set by the manufacturer and subject to change.
  • Patient assistance programs are separate from savings cards and are usually income-based.
  • Program terms change without notice — always confirm on the manufacturer’s official site before relying on them.

The three program types

Savings cards (also called copay cards) reduce what a commercially insured patient pays at the pharmacy counter, usually up to a cap and for a limited period. Federal rules generally prohibit their use by people with Medicare, Medicaid, TRICARE, or other government coverage.

Self-pay channels are manufacturer-operated pharmacies or partnerships that sell the drug directly to cash-paying patients, often at a lower price than list. A prescription from a licensed clinician is still required.

Patient assistance programs provide medication at no or reduced cost to patients who meet income and insurance criteria, typically through an application with documentation.

Where to check current terms

Go directly to the manufacturer’s official product site — those pages are the authoritative source for current eligibility rules and amounts. Each drug page on this site links to the official manufacturer site for that product.

Be cautious with third-party sites that quote specific savings figures; those numbers go stale quickly and we do not republish them.

  • Novo Nordisk (Wegovy, Saxenda, Ozempic): NovoCare
  • Eli Lilly (Zepbound, Mounjaro): Lilly savings programs and LillyDirect
  • Currax (Contrave) and Vivus (Qsymia): manufacturer program pages linked on those drug pages

What to watch out for

Only use programs run by the manufacturer or a licensed pharmacy. Offers that do not require a prescription, or that ship prescription medication from overseas sellers, are not legitimate access routes.

Official manufacturer pages

These are the authoritative sources for current program terms. We link to them rather than restating eligibility rules or dollar amounts that change without notice. None of these are affiliate links.

Manufacturer sites by product
ProductManufacturerOfficial site
WegovyNovo Nordiskwww.wegovy.com
OzempicNovo Nordiskwww.ozempic.com
ZepboundEli Lilly and Companyzepbound.lilly.com
MounjaroEli Lilly and Companymounjaro.lilly.com
SaxendaNovo Nordiskwww.saxenda.com

Last checked: August 12, 2026 — links verified to resolve; program terms not restated here

Programs that are not legitimate

Any offer that ships prescription medication without a prescription, sells “research peptides,” or promises a branded GLP-1 at a fraction of every published price is operating outside the licensed supply chain. We do not link to these. Read our guide to compounded medications for what the FDA has said about unapproved products.

Sources

  1. FDA: Buying medicine online safely (BeSafeRx) FDA. Link last verified August 12, 2026.
  2. NovoCare (Novo Nordisk patient access) Manufacturer. Link last verified August 12, 2026.
  3. LillyDirect (Eli Lilly) Manufacturer. Link last verified August 12, 2026.

Not medical advice. WeightLossDrugsGuide is an independent educational publisher. We are not a pharmacy, a medical provider, or a telehealth clinic, and we do not provide personalized medical recommendations or dosing guidance. Information here summarizes official FDA labeling and other primary sources and may not reflect the most recent changes. Always talk with a licensed clinician about your own situation, and read the full prescribing information for any medication.